Toshifumi
Miyazawa
*,
Kayoko
Tanaka
,
Eiichi
Ensatsu
,
Ryoji
Yanagihara
and
Takashi
Yamada
Department of Chemistry, Faculty of Science, Konan University, Higashinada-ku, Kobe, 658-8501, Japan. Fax: +81-78-435-2539; E-mail: miyazawa@base2.ipc.konan-u.ac.jp
First published on 11th December 2000
In the kinetically controlled approach of peptide synthesis mediated by α-chymotrypsin, the broadening of the protease’s substrate tolerance is achieved by switching the acyl donor from the conventional methyl ester to the carbamoylmethyl ester. Thus, as a typical example, the extremely low coupling efficiency obtained by employing the methyl ester of an inherently poor amino acid substrate, Ala, is significantly improved by the use of this particular ester. Its ameliorating effect is observed also in the couplings of other amino acid residues such as Gly and Ser as carboxy components.
Yield (%)d | |||||
---|---|---|---|---|---|
Entry | R | ν relb | σ*c | Peptide | Z-L-Ala-OH |
a Coupling conditions: Z-L-Ala-OR (0.05 mmol), L-Leu-NH2·HCl (0.2 mmol), TEA (0.2 mmol), immobilised α-chymotrypsin on Celite (150 mg), acetonitrile (2 ml), 0.05 M Tris buffer (pH 7.8) (80 μl), 30 °C. b The initial rate of consumption of the substrate ester was determined through the periodical assay of the reaction mixture over 8 h (4 h and 1 h in the case of moderately fast reacting esters and fast reacting esters, respectively). c Ref. 11. d After 48 h of incubation. e 2.79 × 10−2 mM h−1 mg−1. The value in Table 1 of ref. 3b was misprinted and should be corrected. f Ref. 12. g Corrected for non-enzymic hydrolysis (see Table 2). | |||||
1 | CH3 | 1e | 0 | 6.7 | 1.0 |
2 | CH2CH3 | 0.54 | −0.100 | 4.2 | 0.7 |
3 | (CH2)2CH3 | 0.39 | −0.115 | 2.5 | 0.5 |
4 | CH(CH3)2 | 1.0 | 0 | ||
5 | (CH2)3CH3 | 0.53 | −0.130 | 3.4 | 0.6 |
6 | CH2CH(CH3)2 | 0.76 | −0.125 | 10.2 | 1.0 |
7 | (CH2)4CH3 | 0.34 | 3.0 | 0.4 | |
8 | (CH2)5CH3 | 0.24 | 2.0 | 0.3 | |
9 | C6H11-c | 0.41 | 3.4 | 0.6 | |
10 | CH2C5H9-c | 0.74 | 6.3 | 0.9 | |
11 | CH2C6H11-c | 0.68 | −0.06 | 4.9 | 0.7 |
12 | CH2CF3 | 17.5 | +0.92 | 82.4 | 8.6g |
13 | CH2CF2CF3 | 8.8 | 63.2 | 6.8g | |
14 | CH2CH2Cl | 3.4 | +0.385 | 30.5 | 3.8g |
15 | CH2CCl3 | 14.1 | 87.8 | 6.9g | |
16 | CH2Ph | 4.2 | +0.215 | 28.6 | 4.2 |
17 | CH2C6H4NO2-4 | 18.7 | 79.3 | 9.2 | |
18 | CH2C6H4CN-4 | 11.4 | 72.7 | 9.6 | |
19 | CH2C6H4Cl-4 | 5.3 | 33.6 | 4.0 | |
20 | CH2C6H4OMe-4 | 2.8 | 19.2 | 2.2 | |
21 | CH2C5H4N | 29.1 | 89.9 | 10.0 | |
22 | (CH2)2Ph | 0.61 | +0.080 | 9.1 | 0.7 |
23 | (CH2)3Ph | 0.42 | +0.02 | 6.8 | 0.5 |
24 | CH2CN | 29.6 | +1.30 | 88.3 | 6.4g |
25 | CH2OCH3 | 6.7 | +0.64f | 45.6 | 5.6g |
26 | CH2COCH3 | 6.9 | +0.60 | 43.0 | 7.0g |
27 | CH2COPh | 0.51 | 7.5 | 4.1 | |
28 | CH2CO2Et | 3.0 | 24.0 | 4.1 | |
29 | CH2CONH2 | 133 | 88.4 | 10.9g | |
30 | CH2CONHCH3 | 110 | 89.1 | 10.8g | |
31 | CH2CON(CH3)2 | 4.8 | 34.4 | 5.2 |
Scheme 1 Kinetically controlled peptide synthesis: H-E, serine or cysteine protease; R1CO2R, carboxy component in the form of an ester; R2NH2, amino component. |
Scheme 2 |
With the benzyl ester5 (Entry 16) the peptide yield was improved to a considerable extent, and its p-nitro or p-cyano derivative (Entries 17 and 18, respectively) had a further ameliorating effect, which was comparable to that shown by the above mentioned halogenated alkyl esters. The effect of substituents on the initial rate of consumption of the substrate ester resembled that on the rates of alkaline hydrolysis of substituted-benzyl acetates6 or benzoates.7 Thus, when the p-methoxybenzyl ester (Entry 20) was employed as an acyl donor, the peptide yield was lower than that obtained using the benzyl ester itself. It is interesting to note that the 4-pyridylmethyl ester (Entry 21) afforded a result similar to that given by the p-nitrobenzyl ester. The insertion of a methylene group between the phenyl ring and the ester oxygen atom resulted in a substantial decrease in the peptide yield (Entries 22 and 23), indicating the inductive (electron-withdrawing) effect of the phenyl ring. The importance of the electronic effect, over the steric effect which must be responsible mainly for the stability of the enzyme–substrate (ES) complex, was supported by the fact that the cyclohexylmethyl or cyclopentylmethyl ester (Entry 11 or 10, respectively), which had a steric demand more similar to that of the benzyl ester, exerted no marked influence compared with the other alkyl esters. Accordingly, substituted alkyl esters bearing electron-withdrawing groups other than halogens and phenyl rings were examined next. The cyanomethyl ester8 (Entry 24) increased the peptide yield significantly. In this case, no peptide product was obtained non-enzymically, while spontaneous hydrolysis of the donor ester occurred to some extent (see Table 2).† The methoxymethyl and acetonyl esters (Entries 25 and 26, respectively) had a considerable ameliorating effect. Finally, it was gratifying to find that the carbamoylmethyl ester (Entry 29) was superior to the halogenated alkyl esters. The use of this ester as an enzyme substrate was reported some decades ago.9 It was later examined as a donor ester in the α-chymotrypsin-catalysed coupling of Z- or Boc-Phe conducted in aqueous organic media.10 The chief concern at that time was to take advantage of the better solubility of this ester in the aqueous phase for the coupling of the α-chymotrypsin’s good amino acid substrates. The superiority of the carbamoylmethyl ester can be seen from its reaction profile as compared with those of the other esters, e.g., the methyl and trifluoroethyl esters (Fig. 1): even after 2 h of incubation the peptide yield reached to 77% and the maximum yield (88%) was attained after ca. 6 h.
Yield (%)b | ||
---|---|---|
R | Peptide | Z-L-Ala-OH |
a Reactions were conducted using Z-L-Ala-OR (0.05 mmol), L-Leu-NH2·HCl (0.2 mmol), and TEA (0.2 mmol) in a solvent composed of acetonitrile (2 ml) and 0.05 M Tris buffer (pH 7.8) (80 μl) at 30 °C. b After 48 h. | ||
CH2CF3 | 0 | 1.9 |
CH2CF2CF3 | 0 | 2.3 |
CH2CH2Cl | 0 | 0.2 |
CH2CCl3 | 0 | 2.0 |
CH2CN | 0 | 5.3 |
CH2OCH3 | 0 | 2.9 |
CH2COCH3 | 0 | 1.6 |
CH2CONH2 | 0 | 0.7 |
CH2CONHCH3 | 0 | 0.1 |
Fig. 1 Reaction profiles in the α-chymotrypsin-catalysed couplings of Z-L-Ala-OR with L-Leu-NH2. Symbols: ○, R = CH2CONH2; △, R = CH2CF3; □, R = CH3. |
When the log vrel-value for each ester substrate in Table 1 was plotted against the polar substituent constant, σ*,11 for R, which is a measure of its polar or inductive effect, a rough proportionality was found between them (Fig. 2): the higher the electron-withdrawing ability of the R group, the higher the νrel-value. The log νrel-value corresponds to the relative activation free energy which is dependent both on the stability of the ES complex and on the rate of acyl-enzyme formation. The correlation between log νrel and σ* is indicative of the predominance of the effect of the R group on the acyl-enzyme formation over the binding of the substrate ester onto the enzyme. In the case of the carbamoylmethyl ester, however, its effect on the binding stage must also be relatively important, because the electron-withdrawing ability of this group should not be markedly large compared with other groups, e.g., the acetonyl group (σ* = +0.60), though its σ*-value is not reported in the literature.‡ Carbamoylmethyl esters whose amide hydrogens were substituted by methyl group(s) were examined next (Entries 30 and 31 in Table 1). The monomethylated ester gave almost the same result as the parent ester, while with the dimethylated ester the peptide yield was diminished to a great extent. This result implies the necessity of at least one amide proton of the carbamoylmethyl ester for stabilisation through hydrogen bonding of the ES-complex.
Fig. 2 Plot of log νrel against σ* of R for the α-chymotrypsin-catalysed coupling of Z-L-Ala-OR with L-Leu-NH2 (see Table 1). |
The ameliorating effect of the carbamoylmethyl ester was observed also in the couplings of other amino acid residues as carboxy components. As shown in Table 3, Gly behaved as a poorer amino acid substrate for α-chymotrypsin than did L-Ala, the yield of the desired peptide being negligible even after 48 h of incubation when the methyl ester was used as the acyl donor. In this case also, a marked enhancement of peptide yield by the use of the trifluoroethyl ester and the superiority of the carbamoylmethyl ester over other activated esters were demonstrated. The same trend was observed also among the methyl, trifluoroethyl and carbamoylmethyl esters of L-Ser. But a feature observed only in this particular case was that the p-nitrobenzyl ester was as good a donor ester as the carbamoylmethyl ester. The methyl ester of Z-L-Val failed in the production of the desired peptide, probably due to the steric hindrance caused by the β-branching in the side chain, while the carbamoylmethyl ester managed to give the peptide product, albeit in low yield. This was also the case with another bulky amino acid, α-aminoisobutyric acid (Aib, 2-amino-2-methylpropanoic acid),15 the peptide yield being even lower. Furthermore, the use of the carbamoylmethyl ester allowed even the coupling of a D-amino acid as the carboxy component.16 Thus, the Z-D-Ala ester gave the desired D-L-peptide in moderate yield, although the νrel-value was less than one sixth of that for the L-counterpart. On the other hand, it proved to be quite difficult to obtain the peptide of L-Pro even by the use of the carbamoylmethyl ester.
Yield (%)b | |||
---|---|---|---|
Xaa | R | Peptide | Z-Xaa-OH |
a The coupling conditions were the same as described in Table 1, using 0.05 mmol of acyl donor. b After 48 h. c Corrected for non-enzymic hydrolysis. The yields (%) of Z-Xaa-OH formed after 48 h of incubation under the same conditions as described in Table 2 were as follows: Z-Gly-OCH2CF3, 1.8; Z-Gly-OCH2CONH2, 2.1; Z-L-Ser-OCH2CF3, 10.2; Z-L-Ser-OCH2CONH2, 2.2. The corresponding values in Table 2 of ref. 3b were uncorrected ones. | |||
Gly | CH3 | 0.4 | 0.6 |
CH2CF3 | 74.3 | 9.1c | |
CH2Ph | 3.9 | 1.3 | |
CH2C6H4NO2-4 | 23.4 | 3.3 | |
CH2CONH2 | 90.9 | 6.0c | |
L-Ser | CH3 | 8.7 | 1.2 |
CH2CF3 | 87.9 | 0.5c | |
CH2Ph | 69.7 | 4.6 | |
CH2C6H4NO2-4 | 92.4 | 4.6 | |
CH2CONH2 | 91.3 | 6.3c | |
L-Val | CH3 | 0 | 0.3 |
CH2CF3 | 0.9 | 0.8 | |
CH2CONH2 | 13.6 | 6.8 | |
D-Ala | CH3 | 0 | 0.8 |
CH2CONH2 | 40.6 | 7.0 | |
L-Pro | CH2CF3 | 0.6 | 0.5 |
CH2CONH2 | 0.6 | 0.3 | |
Aib | CH2CONH2 | 6.4 | 1.4 |
In summary, α-chymotrypsin’s narrow substrate specificity was broadened by the use of the carbamoylmethyl ester as the acyl donor in the kinetically controlled approach of peptide synthesis mediated by this protease.
Compound | Molecular formula | C (%) Found (required) | H (%) Found (required) |
---|---|---|---|
Z-L-Ala-OCH2CH3 | C13H17NO4 | 62.21 (62.14) | 6.87 (6.82) |
Z-L-Ala-O(CH2)2CH3 | C14H19NO4 | 63.11 (63.38) | 7.28 (7.21) |
Z-L-Ala-OCH(CH3)2 | C14H19NO4 | 63.39 (63.38) | 7.23 (7.21) |
Z-L-Ala-O(CH2)3CH3 | C15H21NO4 | 64.22 (64.50) | 7.60 (7.58) |
Z-L-Ala-OCH2CH(CH3)2 | C15H21NO4 | 64.33 (64.50) | 7.62 (7.58) |
Z-L-Ala-O(CH2)4CH3 | C16H23NO4 | 65.33 (65.51) | 7.98 (7.90) |
Z-L-Ala-O(CH2)5CH3 | C17H25NO4 | 66.29 (66.43) | 8.23 (8.20) |
Z-L-Ala-OC6H11-c | C17H23NO4 | 66.61 (66.86) | 7.61 (7.59) |
Z-L-Ala-OCH2C5H9-c | C17H23NO4 | 66.71 (66.86) | 7.75 (7.59) |
Z-L-Ala-OCH2C6H11-c | C18H25NO4 | 67.23 (67.69) | 7.82 (7.89) |
Z-L-Ala-OCH2CF3 | C13H14F3NO4 | 51.46 (51.15) | 4.63 (4.62) |
Z-L-Ala-OCH2CF2CF3 | C14H14F5NO4 | 47.51 (47.33) | 3.92 (3.97) |
Z-L-Ala-OCH2CH2Cl | C13H16ClNO4 | 54.70 (54.65) | 5.63 (5.64) |
Z-L-Ala-OCH2CCl3 | C13H14Cl3NO4 | 44.30 (44.03) | 4.06 (3.98) |
Z-L-Ala-OCH2Ph | C18H19NO4 | 68.81 (69.00) | 6.19 (6.11) |
Z-L-Ala-OCH2C6H4NO2-4 | C18H18N2O6 | 60.41 (60.33) | 5.03 (5.06) |
Z-L-Ala-OCH2C6H4CN-4 | C19H18N2O4 | 67.14 (67.45) | 5.24 (5.36) |
Z-L-Ala-OCH2C6H4Cl-4 | C18H18ClNO4 | 62.17 (62.16) | 5.19 (5.22) |
Z-L-Ala-OCH2C6H4OMe-4 | C19H21NO5 | 66.29 (66.46) | 6.14 (6.16) |
Z-L-Ala-O(CH2)2Ph | C19H21NO4 | 69.66 (69.71) | 6.48 (6.47) |
Z-L-Ala-O(CH2)3Ph | C20H23NO4 | 70.25 (70.36) | 6.78 (6.79) |
Z-L-Ala-OCH2CN | C13H14N2O4 | 59.41 (59.54) | 5.54 (5.38) |
Z-L-Ala-OCH2OCH3 | C13H17NO5 | 58.21 (58.42) | 6.47 (6.41) |
Z-L-Ala-OCH2COCH3 | C14H17NO5 | 60.24 (60.21) | 6.19 (6.13) |
Z-L-Ala-OCH2CO2Et | C15H19NO6 | 58.05 (58.25) | 6.16 (6.19) |
Z-L-Ala-OCH2CONHCH3 | C14H18N2O5 | 57.03 (57.14) | 6.24 (6.16) |
Z-L-Ala-OCH2CON(CH3)2 | C15H20N2O5 | 58.08 (58.43) | 6.64 (6.54) |
Z-L-Ser-OCH2CONH2 | C13H16N2O6 | 52.64 (52.70) | 5.54 (5.44) |
Z-L-Val-OCH2CONH2 | C15H20N2O5 | 58.10 (58.43) | 6.73 (6.54) |
Z-L-Pro-OCH2CONH2 | C15H18N2O5 | 58.63 (58.82) | 5.91 (5.92) |
Z-Aib-OCH2CONH2 | C14H18N2O5 | 56.87 (57.14) | 6.02 (6.16) |
Z-D-Ala-L-Leu-NH2 | C17H25N3O4 | 61.08 (60.88) | 7.36 (7.51) |
Z-Gly-L-Leu-NH2 | C16H23N3O4 | 59.72 (59.80) | 7.17 (7.21) |
Z-L-Ser-L-Leu-NH2 | C17H25N3O5·1/2H2O | 56.61 (56.65) | 7.18 (7.27) |
Z-L-Val-L-Leu-NH2 | C19H29N3O4 | 62.69 (62.79) | 8.07 (8.04) |
Z-L-Pro-L-Leu-NH2 | C19H27N3O4 | 62.84 (63.14) | 7.53 (7.53) |
Z-Aib-L-Leu-NH2 | C18H27N3O4 | 61.61 (61.87) | 8.01 (7.79) |
R | Mp (T/°C)a | [α]25D (10−1 deg cm2 g−1)b | IR (ATR) (νmax/cm−1)c | 1H NMR δH (CDCl3) |
---|---|---|---|---|
a Recrystallisation solvent: A, cyclohexane; B, CCl4–petroleum spirit; C, benzene–petroleum spirit; D, CCl4; E, EtOAc; F, EtOAc–petroleum spirit. b c 1.0 in MeOH unless otherwise noted. c Wavenumbers of only the peaks ascribed to the N–H and CO stretching vibrations are quoted. d Lit.,19 mp 45–46 °C; [α]22D −33.9 (c 2, MeOH). e 4-Picolyl ester. Lit.,24 mp 111–112.5 °C; [α]20D −20.2 (c 1.0, DMF). f Lit.,25 mp 154–155 °C; [α]18D −26.5 (c 2.0, CHCl3). g Lit.,26 mp 74–75 °C; [α]24D −16.8 (c 2.0, DMF). | ||||
CH3d | 46–47.5 (A) | −33.8 | 3339, 1752, 1691 | 1.41 (3H, d, J 6.9), 3.75 (3H, s), 4.39 (1H, quint, J 6.9), 5.11 (2H, s), 5.24–5.40 (1H, br d), 7.26–7.40 (5H, m) |
CH2CH3 | oil | −31.1 | 3334, 1720 | 1.27 (3H, t, J 7.2), 1.41 (3H, d, J 6.9), 4.20 (2H, q, J 7.2), 4.36 (1H, quint, J 6.9), 5.11 (2H, s), 5.26–5.44 (1H, br), 7.25–7.40 (5H, m) |
(CH2)2CH3 | oil | −32.0 | 0.94 (3H, t, J 7.5), 1.42 (3H, d, J 7.2), 1.57–1.74 (2H, m), 4.10 (2H, t, J 6.5), 4.39 (1H, quint, J 7.2), 5.11 (2H, s), 5.28–5.42 (1H, br d), 7.26–7.41 (5H, m) | |
CH(CH3)2 | oil | −28.4 | 3347, 1720 | 1.24 (3H, d, J 6.1), 1.26 (3H, d, J 6.1), 1.40 (3H, d, J 6.9), 4.33 (1H, quint, J 6.9), 4.97–5.05 (1H, sept, J 6.1), 5.11 (2H, s), 5.28–5.42 (1H, br d), 7.26–7.41 (5H, m) |
(CH2)3CH3 | oil | −29.0 | 3349, 1721 | 0.93 (3H, t, J 7.5), 1.27–1.43 (2H, m), 1.41 (3H, d, J 7.2), 1.54–1.69 (2H, m), 4.14 (2H, t, J 6.6), 4.38 (1H, quint, J 7.2), 5.11 (2H, s), 5.26–5.41 (1H, br d), 7.27–7.42 (5H, m) |
CH2CH(CH3)2 | oil | −31.3 | 3349, 1722 | 0.93 (6H, d, J 6.6), 1.43 (3H, d, J 7.2), 1.86–2.02 (1H, m), 3.82–4.00 (2H, m), 4.40 (1H, quint, J 7.2), 5.11 (2H, s), 5.28–5.42 (1H, br d), 7.26–7.40 (5H, m) |
(CH2)4CH3 | oil | −29.1 | 3342, 1723 | 0.90 (3H, t, J 6.9), 1.23–1.37 (4H, m), 1.41 (3H, d, J 7.2), 1.59–1.69 (2H, m), 4.13 (2H, t, J 6.8), 4.38 (1H, quint, J 7.2), 5.11 (2H, s), 5.27–5.41 (1H, br d), 7.26–7.40 (5H, m) |
(CH2)5CH3 | oil | −27.6 | 3355, 1723 | 0.89 (3H, t, J 6.9), 1.19–1.40 (6H, m), 1.42 (3H, d, J 7.2), 1.57–1.68 (2H, m), 4.13 (2H, t, J 6.5), 4.38 (1H, quint, J 7.2), 5.11 (2H, s), 5.28–5.40 (1H, br d), 7.26–7.38 (5H, m) |
C6H11-c | 57.5–58.5 (B) | −31.1 | 3363, 1751, 1694 | 1.17–1.90 (10H, m), 1.41 (3H, d, J 7.2), 4.35 (1H, quint, J 7.2), 4.74–4.86 (1H, m), 5.11 (2H, s), 5.28–5.41 (1H, br d), 7.26–7.40 (5H, m) |
CH2C5H9-c | oil | −30.5 | 3335, 1722 | 1.10–1.82 (8H, m), 1.42 (3H, d, J 7.2), 2.11–2.37 (1H, m), 3.93–4.10 (2H, m), 4.38 (1H, quint, J 7.2), 5.11 (2H, s), 5.28–5.42 (1H, br d), 7.27–7.40 (5H, m) |
CH2C6H11-c | oil | −25.7 | 3357, 1735, 1709 | 0.84–1.82 (11H, m), 1.42 (3H, d, J 7.2), 3.85–4.30 (2H, m), 4.39 (1H, quint, J 7.2), 5.11 (2H, s), 5.37 (1H, br d, J 6.9), 7.26–7.42 (5H, m) |
CH2CF3 | 59 (B) | −28.6 | 3331, 1773, 1683 | 1.46 (3H, d, J 7.2), 4.34–4.54 (2H, m), 4.54–4.70 (1H, m), 5.12 (2H, AB q, J 13), 5.16–5.29 (1H, br), 7.26–7.41 (5H, m) |
CH2CF2CF3 | 56–56.5 (A) | −27.6 | 3351, 1756, 1687 | 1.45 (3H, d, J 7.5), 4.40–4.57 (2H, m), 4.72 (1H, AB q, J 13), 5.12 (2H, AB q, J 12), 5.18–5.29 (1H, br d), 7.27–7.41 (5H, m) |
CH2CH2Cl | 53–54 (B) | −30.3 | 3330, 1752, 1691 | 1.44 (3H, d, J 7.2), 3.67 (2H, t, J 5.6), 4.23–4.51 (3H, m), 5.11 (2H, s), 5.21–5.36 (1H, br), 7.25–7.45 (5H, m) |
CH2CCl3 | oil | −31.7 | 3327, 1763, 1705 | 1.51 (3H, d, J 7.2), 4.54 (1H, quint, J 7.2), 4.65 and 4.93 (2H, AB q, J 12), 5.12 (2H, AB q, J 12), 5.23–5.36 (1H, br d), 7.27–7.40 (5H, m) |
CH2Ph | 38–39 (B) | −31.4 | 3338, 1747, 1688 | 1.42 (3H, d, J 7.2), 4.44 (1H, quint, J 7.2), 5.11 (2H, s), 5.17 (2H, AB q, J 12), 5.29–5.40 (1H, br d), 7.24–7.43 (10H, m) |
CH2C6H4NO2-4 | 100.5–101 (C) | −17.2 | 3324, 1744, 1688 | 1.46 (3H, d, J 7.2), 4.47 (1H, quint, J 7.2), 5.12 (2H, s), 5.15–5.34 (1H, br), 5.27 (2H, AB q, J 9.3), 7.24–7.40 (5H, m), 7.55 (2H, d, J 8.4), 8.22 (2H, d, J 8.4) |
CH2C6H4CN-4 | 91.5–92.5 (D) | −20.0 | 3333, 1743, 1685 | 1.44 (3 H, d, J 7.2), 4.46 (1H, quint, J 7.2), 5.11 (2H, s), 5.22 (2H, AB q, J 15), 5.24–5.34 (1H, br d), 7.23–7.40 (5H, m), 7.43 and 7.62 (4H, AB q, J 8.0) |
CH2C6H4Cl-4 | 88.5–89.5 (A) | −25.4 | 3300, 1736, 1689 | 1.41 (3H, d, J 7.2), 4.43 (1H, quint, J 7.2), 5.10 (2H, s), 5.13 (2H, AB q, J 12), 5.21–5.35 (1H, br d), 7.15–7.40 (9H, m) |
CH2C6H4OMe-4 | 61 (D) | −29.8 | 3336, 1735, 1686 | 1.40 (3H, d, J 7.2), 3.81 (3H, s), 4.40 (1H, quint, J 7.2), 5.10 (4H, s), 5.27–5.37 (1H, br d), 6.88 and 7.28 (4H, AB q, J 8.4), 7.30–7.40 (5H, m) |
CH2C5H4Ne | 113–114 (E) | −18.8 (DMF) | 3215, 1747, 1709 | 1.47 (3H, d, J 7.2), 4.49 (1H, quint, J 7.2), 5.12 (2H, s), 5.19 (2H, AB q, J 13), 5.32–5.45 (1H, br d), 7.23 (2H, d, J 5.4), 7.27–7.40 (5H, m), 8.60 (2H, d, J 5.4) |
(CH2)2Ph | oil | −32.6 | 3307, 1734, 1682 | 1.34 (3H, d, J 7.2), 2.95 (2H, t, J 6.9), 4.27–4.43 (3H, m), 5.10 (2H, s), 5.24–5.36 (1H, br d), 7.16–7.41 (10H, m) |
(CH2)3Ph | 49–50 (D) | −24.7 | 3304, 1738, 1686 | 1.42 (3H, d, J 7.7), 1.95–2.04 (2H, m), 2.68 (2H, t, J 12), 4.16 (2H, t, J 6.6), 4.39 (1H, quint, J 7.7), 5.11 (2H, s), 5.24–5.37 (1H, br d), 7.11–7.40 (10H, m) |
CH2CN | oil | −45.3 | 3329, 1762, 1705 | 1.46 (3H, d, J 7.2), 4.46 (1H, quint, J 7.2), 4.76 (2H, AB q, J 17), 5.11 (2H, AB q, J 14), 5.21–5.34 (1H, br d), 7.26–7.42 (5H, m) |
CH2OCH3 | oil | −36.6 | 3352, 1801, 1713 | 1.45 (3H, d, J 6.9), 3.46 (3H, s), 4.42 (1H, quint, J 6.9), 5.11 (2H, AB q, J 12), 5.25 and 5.33 (2H, AB q, J 6.0), 5.28–5.40 (1H, br), 7.27–7.40 (5H, m) |
CH2COCH3 | 68–68.5 (D) | −43.0 | 3333, 1756, 1725, 1692 | 1.51 (3H, d, J 7.2), 2.16 (3H, s), 4.50 (1H, quint, J 7.2), 4.64 and 4.78 (2H, AB q, J 17), 5.11 (2H, AB q, J 13), 5.23–5.38 (1H, br d), 7.27–7.41 (5H, m) |
CH2COPhf | 156–157 (E) | −24.8 (CHCl3) | 3367, 1754, 1687 | 1.58 (3H, d, J 7.2), 4.58 (1H, quint, J 7.2), 5.12 (2H, AB q, J 12), 5.29 and 5.51 (2H, AB q, J 17), 5.34 (1H, br d, J 8.1), 7.26–7.40 (5H, m), 7.44–7.97 (5H, m) |
CH2CO2Et | 50–52.5 (A) | −46.6 | 3329, 1761, 1744, 1686 | 1.28 (3H, t, J 7.2), 1.50 (3H, d, J 7.2), 4.22 (2H, q, J 7.2), 4.50 (1H, quint, J 7.2), 4.56 and 4.76 (1H, AB q, J 16), 5.12 (2H, AB q, J 13), 5.23–5.38 (1H, br d), 7.26–7.41 (5H, m) |
CH2CONH2g | 71.5–72.5 (F) | −16.3 (DMF) | 3421, 3328, 1747, 1711, 1686 | 1.46 (3H, d, J 7.2), 4.33 (1H, quint, J 7.2), 4.63 (2H, AB q, J 16), 5.10 (2H, AB q, J 11), 5.44 (1H, br), 5.73 (1H, br), 6.78 (1H, br), 7.28–7.41 (5H, m) |
CH2CONHCH3 | 98.5–99 (E) | −21.8 | 1.46 (3H, d, J 7.2), 2.78 (3H, d, J 4.8), 4.31 (1H, quint, J 7.2), 4.64 (2H, AB q, J 16), 5.12 (2H, AB q, J 12), 5.31–5.42 (1H, br d), 6.80 (1H, br), 7.28–7.41 (5H, m) | |
CH2CON(CH3)2 | oil | −40.7 | 3308, 1753, 1716, 1663 | 1.53 (3H, d, J 7.2), 2.95 (6H, s), 4.51 (1H, quint, J 7.2), 4.67 and 4.87 (2H, AB q, J 14), 5.11 (2H, AB q, J 11), 5.44 (1H, br d), 7.27–7.39 (5H, m) |
Xaa | Mp (T/°C)a | [α]25D (10−1 deg cm2 g−1)b | IR (ATR) (νmax/cm−1)c | 1H NMR |
---|---|---|---|---|
a From EtOAc. b c 1.0 in MeOH. c Wavenumbers of only the peaks ascribed to the N–H and CO stretching vibrations are quoted. d Lit.,26 mp 105–108 °C. | ||||
Glyd | 104–105.5 | 3446, 3328, 1770, 1745, 1687 | δ H (DMSO-d6) 3.89 (2H, d, J 6.0), 4.45 (2H, s), 5.04 (2H, s), 7.22–7.37 (6H, m), 7.44 (1H, br), 7.75 (1H, t, J 6.0) | |
L-Ser | 122.5–124 | −16.6 | 3308, 1766, 1684 | δ H (DMSO-d6) 3.61–3.79 (2H, m), 4.24–4.31 (1H, m), 4.47 (2H, AB q, J 15), 5.04 (2H, s), 5.14 (1H, t, J 5.7), 7.24–7.46 (7H, m), 7.68 (1H, d, J 7.8) |
L-Val | 89–89.5 | −17.5 | 3445, 3317, 1750, 1707, 1666 | δ H (CDCl3) 0.98 (3H, d, J 6.9), 1.02 (3H, d, J 6.9), 2.05–2.24 (1H, m), 4.16 (1H, dd, J 7.1 and 6.3), 4.55 and 4.73 (2H, AB q, J 16), 5.10 (2H, s), 5.36 (1H, br d, J 7.1), 5.73 (1H, br), 6.70 (1H, br), 7.28–7.42 (5H, m) |
L-Pro | oil | −53.8 | 3339, 1754, 1678 | δ H (CDCl3) 1.87–2.36 (4H, m), 3.50–3.69 (2H, m), 4.37–4.47 (1H, m), 4.65 (2H, AB q, J 16), 5.14 (2H, s), 5.49 (1H, br), 7.21 (1H, br), 7.28–7.43 (5H, m) |
Aib | 153.5–154.5 | 3373, 3284, 1745, 1675 | δ H (DMSO-d6) 1.39 (6H, s), 4.40 (2H, s), 5.01 (2H, s), 7.18 (1H, br), 7.30–7.40 (6H, m), 7.94 (1H, br) |
(i) The methyl esters were prepared through treatment of the corresponding N-Z-amino acids with an ethereal solution of diazomethane in a nearly quantitative yield. Z-Gly-OMe: oil; Z-L-Ser-OMe: oil; [α]25D −14.0 (c 1.0, MeOH) {lit.,17 mp 45–46 °C; [α]22D −12.5 (c 1, MeOH)}; Z-L-Val-OMe: oil; [α]25D −19.4 (c 1.0, MeOH) {lit.,18 mp 54–55 °C; [α]20D −18.9 (c 1, MeOH)}; Z-D-Ala-OMe: mp 47–48.5 °C; [α]25D +33.8 (c 1.0, MeOH).
(ii) The following esters were prepared through the reaction of an N-Z-amino acid (2.2 mmol) with the corresponding alcohol (2.5 mmol for the group A esters or 2.1 mmol for the group B esters) in the presence of DMAP (135 mg, 1.1 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC·HCl) (460 mg, 2.4 mmol) in DCM (8 ml) according to the procedure of Dhaon et al.:19 (A) ethyl, n-propyl, isopropyl, n-butyl, isobutyl, cyclohexyl, cyclopentylmethyl, cyclohexylmethyl, 2,2,2-trifluoroethyl, 2,2,3,3,3-pentafluoropropyl, 2-chloroethyl, or 2,2,2-trichloroethyl ester; (B) n-pentyl, n-hexyl, benzyl, 4-chlorobenzyl, 4-methoxybenzyl, 2-phenylethyl, 3-phenylpropyl, or ethoxycarbonylmethyl ester.
Z-Gly-OCH2CF3: mp 73–73.5 °C (Found: C, 49.56; H, 4.10; N, 4.87. C12H12F3NO4 requires C, 49.49; H, 4.15; N, 4.81%); Z-Gly-OCH2Ph: mp 71–72 °C (Found: C, 68.26; H, 5.84; N, 4.70. C17H17NO4 requires C, 68.22; H, 5.72; N, 4.68%); Z-L-Ser-OCH2CF3: mp 73–77 °C; [α]25D −14.2 (c 1.0, MeOH) (Found: C, 48.87; H, 4.36; N, 4.48. C13H14F3NO5 requires C, 48.60; H, 4.39; N, 4.36%); Z-L-Val-OCH2CF3: mp 58 °C; [α]25D −17.8 (c 1.0, MeOH) (Found: C, 53.97; H, 5.42; N, 4.24. C15H18F3NO4 requires C, 54.05; H, 5.44; N, 4.20%); Z-L-Pro-OCH2CF3: oil; [α]25D −48.8 (c 1.0, MeOH) (Found: C, 54.17; H, 4.87; N, 4.23. C15H16F3NO4 requires C, 54.38; H, 4.87; N, 4.23%).
(iii) The following esters were prepared via reaction of the Ce salt of an N-Z-amino acid with the corresponding chloride:20 the carbamoylmethyl, cyanomethyl, methoxymethyl, acetonyl, benzoylmethyl, N-methylcarbamoylmethyl, or N,N-dimethylcarbamoylmethyl ester. The preparation of the carbamoylmethyl ester of Z-L-Ala is described as a typical example. To a solution of Z-L-Ala (447 mg, 2 mmol) in MeOH (4 ml) was added a solution of Cs2CO3 (326 mg, 1 mmol) in water (1.5 ml), and the mixture was evaporated under reduced pressure. After repeated evaporation to dryness with toluene, the residue was stored over P4O10 in a vacuum desiccator. The Ce salt of Z-L-Ala thus obtained was mixed with 2-chloroacetamide (187 mg, 2 mmol) in DMF (8 ml) and the mixture was stirred at 60 °C overnight. The mixture was distributed between EtOAc (40 ml) and water (10 ml), and the aqueous phase was extracted further with EtOAc (2 × 10 ml), and the combined organic extracts were washed successively with 1 M aq. NaHCO3 and water and dried over Na2SO4. Evaporation of the solvent afforded white crystals, which were recrystallised from EtOAc–petroleum spirit; yield 485 mg (87%).
The benzyl ester of Z-L-Ser was also prepared by the same route: mp 83–83.5 °C; [α]25D +3.8 (c 1.0, CHCl3) {lit.,21 mp 83–84 °C; [α]20D +5.1 (c 2.95, CHCl3)}.
(iv) The 4-nitrobenzyl and 4-cyanobenzyl esters were prepared via reaction of the triethylamine (TEA) salt of an N-Z-amino acid with the corresponding bromide.22 The preparation of the 4-nitrobenzyl ester of Z-L-Ala is described as a typical example. A mixture of Z-L-Ala (447 mg, 2 mmol), 4-nitrobenzyl bromide (432 mg, 2 mmol), and TEA (202 mg, 2 mmol) in EtOAc (7 ml) was refluxed for 8.5 h. The white precipitate was filtered off and the filtrate was washed successively with 2 M HCl, water, 1 M aq. NaHCO3 and brine, and dried over Na2SO4. Evaporation of the solvent in vacuo afforded white crystals, which were recrystallised from benzene–petroleum spirit; yield 464 mg (65%).
Z-Gly-OCH2C6H4(4NO2): mp 111 °C (lit.,23 107–109.5 °C); Z-L-Ser-OCH2C6H4(4NO2): mp 117.5–118 °C; [α]25D −10.8 (c 1.0, MeOH) {lit.,21 mp 116–117 °C; [α]20D −11.0 (c 1, MeOH)}.
(v) The 4-picolyl ester24 of Z-L-Ala was prepared by stirring a mixture of Z-L-Ala (447 mg, 2 mmol), 4-picolyl chloride hydrochloride (392 mg, 2 mmol), and 1,1,3,3-tetramethylguanidine (461 mg, 4 mmol) in DMF (7 ml) at 90 °C for 9 h. Similar work-up as above yielded pale yellow crystals, which were recrystallised from EtOAc; yield 392 mg (62%).
Xaa | Mp (T/°C)a | [α]25D (10−1 deg cm2 g−1)b | 1H NMR δH (DMSO-d6) |
---|---|---|---|
a From aq. EtOH. b c 1.0 in MeOH unless otherwise noted. c Lit.,10 mp 187–189 °C; [α]22D −17.1 (c 1, DMF). d −43.7 in MeOH. | |||
L-Alac | 191–191.5 | −18.3 (DMF)d | 0.82 (3H, d, J 6.5), 0.85 (3H, d, J 6.5), 1.17 (3H, d, J 7.2), 1.40–1.46 (2H, t-like), 1.48–1.65 (1H, m), 3.93–4.11 (1H, quint-like), 4.16–4.24 (1H, q-like), 5.00 (2H, s), 6.97 (1H, s), 7.28 (1H, s), 7.19–7.40 (5H, m), 7.46 (1H, br d, J 8.4), 7.77 (1H, br d, J 8.4) |
D-Ala | 189.5–191 | −2.8 | 0.81 (3H, d, J 6.0), 0.85 (3H, d, J 6.0), 1.18 (3H, d, J 6.9), 1.25–1.61 (3H, m), 3.99–4.10 (1H, quint-like), 4.14–4.23 (1H, m), 5.00 (2H, s), 7.04 (1H, s), 7.25 (1H, s), 7.21–7.39 (5H, m), 7.47 (1H, d, J 7.2), 8.01 (1H, d, J 8.4) |
Gly | 124–126 | −19.1 | 0.82 (3H, d, J 6.5), 0.86 (3H, d, J 6.5), 1.36–1.64 (3H, m), 3.55–3.72 (2H, m), 4.16–4.28 (1H, q-like), 5.02 (2H, s), 7.00 (1H, s), 7.24–7.40 (6H, m), 7.44 (1H, t, J 5.7), 7.88 (1H, d, J 8.1) |
L-Ser | 184–184.5 | −19.6 | 0.82 (3H, d, J 6.3), 0.86 (3H, d, J 6.3), 1.40–1.50 (2H, m), 1.50–1.67 (1H, m), 3.56 (2H, t, J 5.9), 4.04–4.11 (1H, q-like), 4.16–4.24 (1H, m), 5.02 (2H, s), 5.04 (1H, t, J 5.4), 7.04 (1H, s), 7.27–7.40 (7H, m), 7.96 (1H, d, J 8.7) |
L-Val | 260–261 | −43.7 | 0.80–0.88 (12H, m), 1.32–1.48 (2H, m), 1.48–1.66 (1H, m), 1.87–2.04 (1H, m), 3.84 (1H, dd, J 8.7 and 6.9), 4.21–4.29 (1H, m), 5.02 (2H, s), 6.96 (1H, s), 7.30–7.40 (7H, m), 7.80 (1H, d, J 8.4) |
L-Pro | 189–194 | −78.2 | 0.67–0.95 (6H, m), 1.29–1.64 (3H, m), 1.71–1.89 (3H, m), 2.01–2.21 (3H, m), 3.27–3.52 (2H, m), 4.13–4.32 (2H, m), 4.78–5.13 (2H, m), 6.94 and 6.99 (1H, s + s), 7.16–7.41 (6H, m), 7.95 and 7.98 (1H, d + d, J 7.5) |
Aib | 137.5–139 | −28.4 | 0.79 (3H, d, J 6.0), 0.84 (3H, d, J 6.0), 1.31 (6H, s), 1.44–1.60 (3H, m), 4.08–4.18 (1H, m), 4.99 (2H, AB q, J 13), 7.00 (1H, s), 7.11 (1H, s), 7.26–7.38 (5H, m), 7.57 (1H, s), 7.65 (1H, br d, J 8.4) |
Footnotes |
† Non-enzymic peptide synthesis was not detected when the other activated esters were employed, while a small amount of the donor ester was hydrolysed non-enzymically in some cases, as shown in Table 2. In Table 1, corrections were made for non-enzymic hydrolysis. |
‡ The σ*-value for the carbamoylmethyl group is estimated to be +0.59 according to the following equation,13 pKa(RCO2H) = −1.700σ*(R) + 4.644, by employing the reported Ka-value for propanedioic acid monoamide (2.284 × 10−4 at 25 °C).14 |
This journal is © The Royal Society of Chemistry 2001 |